Skip to main content

Sara García González

Institutions of which they are part

Research technician
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Sara García González

Institutions of which they are part

Research technician
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INCREM) in patients with Depression.

IP: Amanda Rodríguez Urrutia
Collaborators: Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Gemma Nieva Rifa, Julia Vendrell Serres, Sara García González
Funding agency: Fundació La Marató de TV3
Funding: 60872.31
Reference: 202227-30-31-32-33
Duration: 30/04/2023 - 30/04/2026

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Rafael Rodríguez Lecoq

Rafael Rodríguez Lecoq

Main researcher
Read more
Manuel Jesus Iglesias Cabezas

Manuel Jesus Iglesias Cabezas

Predoctoral researcher
Microbiology
Read more
Elisa Merino Peña

Elisa Merino Peña

Predoctoral researcher
Molecular Medical Imaging
Read more
Pau Torrella Llauger

Pau Torrella Llauger

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.